Ortho-Clinical Diagnostics, Inc., (OCD) has obtained CE Mark for the ORTHO VISION Analyzer, an interactive, fully automated analyzer for transfusion medicine laboratories. The ORTHO VISION Analyzer for ORTHO Column Agglutination Technologies will be commercially available in Europe, Japan, and Australia.
Robert Yates, Ortho Clinical Diagnostics Chief Operating Officer, says, “The ORTHO VISION Analyzer’s unique pairing of secure monitoring technologies and dynamic work flow management is a significant advance that offers labs the ability to address unpredictable demands when needed and have confidence in the results.” Yates continues, “With the launch of the ORTHO VISION Analyzer and responsive automation, our goal is to greatly improve the safety of blood transfusions by reducing the lab’s reliance on manual methods.”
According to company spokespersons, the analyzer is designed with secure monitoring technologies for responsive safety checks and balances, and it gives transfusion medicine professionals the ability to track every critical automated step in the immunohematology testing process. “Through Ortho-Clinical Diagnostics’ proprietary IntelliCheck Technology, the ORTHO VISION Analyzer verifies and documents diagnostic checks throughout the sampling process, while e-Connectivity provides 24/7 remote data tracking that monitors and ensures instrument performance while maximizing uptime. Laboratory personnel can also log on anytime, anywhere to collaborate on interpreting results in real time.” Learn more about solutions provided by Ortho-Clinical Diagnostics.
Read more
